Amarin Corporation plc [NASDAQ: AMRN] closed the trading session at $1.40 on 07/12/22. The day’s price range saw the stock hit a low of $1.29, while the highest price level was $1.45. The company report on June 30, 2022 that REDUCE-IT Exploratory Post Hoc Biomarker Sub-Analysis Shows Relatively Small Changes in Inflammatory Markers Between Icosapent Ethyl and Placebo.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
— Sub-Analysis Findings Support Prior Analyses that Eicosapentaenoic Acid (EPA) Level is The Major Determinant of Benefit in REDUCE-IT –.
Amarin Corporation plc (NASDAQ:AMRN) today announced an exploratory post hoc sub-analysis of REDUCE-IT serum samples that found statin-treated patients allocated to icosapent ethyl (IPE) had limited differences in certain lipid and inflammatory biomarkers compared with statin-treated patients allocated to mineral oil placebo. These findings are consistent with prior reported data and support previous analyses that demonstrated the majority of benefit from IPE was from achieved eicosapentaenoic acid (EPA) levels in REDUCE-IT. This sub-analysis was published online today in the journal Circulation.
The stocks have a year to date performance of -58.46 percent and weekly performance of -11.95 percent. The stock has been moved at -56.92 percent over the last six months. The stock has performed -21.35 percent around the most recent 30 days and changed -58.82 percent over the most recent 3-months.
If compared to the average trading volume of 4.85M shares, AMRN reached to a volume of 5342525 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Amarin Corporation plc [AMRN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRN shares is $3.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Amarin Corporation plc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on May 06, 2022. While these analysts kept the previous recommendation, SVB Leerink raised their target price from $10 to $3. The new note on the price target was released on May 05, 2022, representing the official price target for Amarin Corporation plc stock. Previously, the target price had yet another drop from $10 to $3, while H.C. Wainwright kept a Neutral rating on AMRN stock.
The Average True Range (ATR) for Amarin Corporation plc is set at 0.16, with the Price to Sales ratio for AMRN stock in the period of the last 12 months amounting to 1.01. The Price to Book ratio for the last quarter was 0.87, with the Price to Cash per share for the same quarter was set at 0.94.
AMRN stock trade performance evaluation
Amarin Corporation plc [AMRN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -11.95. With this latest performance, AMRN shares dropped by -21.35% in over the last four-week period, additionally sinking by -56.92% over the last 6 months – not to mention a drop of -68.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRN stock in for the last two-week period is set at 37.14, with the RSI for the last a single of trading hit 32.98, and the three-weeks RSI is set at 38.70 for Amarin Corporation plc [AMRN]. The present Moving Average for the last 50 days of trading for this stock 1.6480, while it was recorded at 1.5160 for the last single week of trading, and 3.2008 for the last 200 days.
Amarin Corporation plc [AMRN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Amarin Corporation plc [AMRN] shares currently have an operating margin of +4.15 and a Gross Margin at +78.71. Amarin Corporation plc’s Net Margin is presently recorded at +1.33.
Return on Equity for this stock inclined to 1.19, with Return on Assets sitting at 0.76.
Amarin Corporation plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.70 and a Current Ratio set at 2.60.
Earnings per share (EPS) analysis for Amarin Corporation plc [AMRN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amarin Corporation plc go to 38.90%.
Amarin Corporation plc [AMRN]: Insider Ownership positions
There are presently around $190 million, or 34.80% of AMRN stock, in the hands of institutional investors. The top three institutional holders of AMRN stocks are: SARISSA CAPITAL MANAGEMENT LP with ownership of 24,000,000, which is approximately 24.675% of the company’s market cap and around 0.30% of the total institutional ownership; BAKER BROS. ADVISORS LP, holding 21,169,805 shares of the stock with an approximate value of $30.27 million in AMRN stocks shares; and EVERSEPT PARTNERS, LP, currently with $12.84 million in AMRN stock with ownership of nearly -15.068% of the company’s market capitalization.
Positions in Amarin Corporation plc stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 83 institutional holders increased their position in Amarin Corporation plc [NASDAQ:AMRN] by around 20,459,864 shares. Additionally, 91 investors decreased positions by around 23,634,758 shares, while 93 investors held positions by with 88,538,426 shares. The mentioned changes placed institutional holdings at 132,633,048 shares, according to the latest SEC report filing. AMRN stock had 28 new institutional investments in for a total of 8,282,636 shares, while 38 institutional investors sold positions of 19,232,842 shares during the same period.